Treatment with niacin lowers ADMA [2]

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 448-450

  Westphal, Sabine ^a   Borucki, Katrin ^a   Luley, Claus ^a   Martens Lobenhoffer, Jens ^a   Bode Böger, Stefanie M ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

ADMA; Homocysteine; Nicotinic acid; Renal function; SDMA

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NICOTINIC ACID;

ATHEROSCLEROSIS; BLOOD SAMPLING; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; HUMAN; LETTER; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTILIPEMIC AGENTS; ARGININE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NIACIN; NITRIC OXIDE SYNTHASE; RISK FACTORS; TREATMENT OUTCOME;

EID: 30044448790     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.018     Document Type: Letter

References (22)

1. A.J. Taylor, L.E. Sullenberger, H.J. Lee, J.K. Lee, and K.A. Grace Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins Circulation 110 2004 3512 3517
2. J.P. Cooke Asymmetrical dimethylarginine. The Über Marker Circulation 109 2004 1813 1819
3. F. Mallamaci, G. Tripepi, S. Cutrupi, L.S. Malatino, and C. Zoccali Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD Kidney Int 67 2005 2330 2337
4. S.W. Bae, M.C. Stuhlinger, and H.S. Yoo Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment Am J Cardiol 95 2005 729 733
5. V.P. Valkonen, H. Paiva, and J.T. Salonen Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 358 2001 2127 2128
6. S.H. Mudd, and J.R. Poole Labile methyl balances for normal humans on various dietary regimens Metabolism 24 1975 721 735
7. P.J. Drinka, and E. Langer The Cockroft-Gault formula J Am Geriatr Soc 37 1989 820
8. J. Martens-Lobenhoffer, O. Krug, and S.M. Bode-Boger Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique J Mass Spectrom 39 2004 1287 1294
9. B. Vester, and K. Rasmussen High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum Eur J Clin Chem Clin Biochem 29 1991 549 554
10. K. Shibata, and H. Matsuo Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methylnicotinamide, N'-methyl-2-pyridone-5-carboxamide, and N'-methyl-4-pyridone-3-carboxamide, in humans consuming a self-selected food Am J Clin Nutr 50 1989 114 119
11. D.A. Jencks, and R.G. Mathews Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium J Biol Chem 262 1987 2485 2493
12. J. Selhub, and J.W. Miller The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine Am J Clin Nutr 55 1992 131 138
13. R. Garg, M. Malinow, M. Pettinger, B. Upson, and D. Hunninghake Niacin treatment increases plasma homocyst(e)ine levels Am Heart J 138 1999 1082 1087
14. D.H. Blankenhorn, R.L. Johnson, S.A. Nessim, S.P. Azen, M.E. Sanmarco, and R.H. Selzer The cholesterol lowering atherosclerosis study (CLAS): design, methods, and baseline results Control Clin Trials 8 1987 356 387
15. R.H. Boger, K. Sydow, and J. Borlak LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases Circ Res 87 2000 99 105
16. T.M. Lu, Y.A. Ding, H.B. Leu, W.H. Yin, W.H. Sheu, and K.M. Chu Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia Am J Cardiol 94 2004 157 161
17. V.P. Valkonen, J. Laakso, and H. Paiva Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels? Atheroscler Suppl 4 2003 19 22
18. H. Paiva, J. Laakso, T. Lehtimaki, M. Isomustajarvi, I. Ruokonen, and R. Laaksonen Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors J Cardiovasc Pharmacol 41 2003 219 222
19. H.M. Eid, J. Eritsland, J. Larsen, H. Arnesen, and I. Seljeflot Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin Atherosclerosis 166 2003 279 284
20. D.P. Holden, J.E. Cartwright, S.S. Nussey, and G.S. Whitley Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine Circulation 108 2003 1575 1580
21. M.C. Stuhlinger, F. Abbasi, and J.W. Chu Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor JAMA 287 2002 1420 1426
22. T. Asagami, F. Abbasi, and M. Stuelinger Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes Metabolism 51 2002 843 846